FDA Inspection
Luzhou Credit Pharmaceutical Co., Ltd.Luzhou Credit Pharmaceutical Co., Ltd. – FDA Inspection, Oct 18, 2019
Record Details
This FDA Inspection record concerns Luzhou Credit Pharmaceutical Co., Ltd., with an inspection on October 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 18, 2019
- Product Type
- Drugs
View Company Profile
ID · 3f08a59e-66e3-4382-9193-342d91397764
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1110329
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Luzhou Credit Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 6, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Luzhou Credit Pharmaceutical Co., Ltd.
- FDA Inspection 936413 - 2015-07-02
- FDA Inspection 791797 - 2012-06-21
- FDA Inspection 684993 - 2010-08-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.